Product Information

PERAMPANEL 10 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $17.5030 per EA under NDC 00480706756. Its NADAC has been published 31 times since Jan 21, 2026.

FDA first approved this application on May 23, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PERAMPANEL 10 MG TABLET

Perampanel
$17.5030per EA
DEA Schedule CIII

Strength

10 mg/1

NDC

00480706756

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PERAMPANEL

Approval Type

Generic (ANDA)

FDA Application

ANDA209801

FDA Approved

5/23/2025

TE Code

AB

On Market Since

5/29/2025

Pharmacological Classes

AMPA Receptor Antagonists
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 3A4 Inhibitors
Noncompetitive AMPA Glutamate Receptor Antagonist
UGT1A9 Inhibitors
UGT2B7 Inhibitors

Price Statistics

The NADAC for PERAMPANEL 10 MG TABLET has been published 31 times since Jan 21, 2026, and over the history we have for it it has declined 45.0%. The table below summarizes its recorded NADAC range and movement.

Current price$17.5030 per EA
All-time high$31.8038 (Feb 11, 2026)
All-time low$17.5030 (Aug 19, 2026)
52-week high$31.8038
52-week low$17.5030
Median price$25.2429
Average price$25.1004
Largest weekly change-15.0% (May 20, 2026)
Weeks tracked31
Tracking sinceJan 21, 2026

Price History

1W

-6.9%

1M

-6.9%

3M

-18.4%

6M

-45.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

-45.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PERAMPANEL 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PERAMPANEL 10 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $17.5030 per EA (NDC 00480706756), effective Aug 19, 2026.

How has the price of PERAMPANEL 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for PERAMPANEL 10 MG TABLET has declined 45.0%. It has been tracked across 31 weekly CMS publications since Jan 21, 2026.

What are the highest and lowest recorded NADAC prices for PERAMPANEL 10 MG TABLET?

Since Jan 21, 2026, the NADAC for PERAMPANEL 10 MG TABLET has ranged from a low of $17.5030 (Aug 19, 2026) to a high of $31.8038 (Feb 11, 2026), with a median of $25.2429 per EA.

Are there cheaper alternatives to PERAMPANEL 10 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PERAMPANEL 10 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PERAMPANEL 10 MG TABLET?

PERAMPANEL 10 MG TABLET (NDC 00480706756) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.